Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
Tanaka K, Koga M, Lee KJ, Kim BJ, Park EL, Lee J, Mizoguchi T, Yoshimura S, Cha JK, Lee BC, Nakahara J, Suzuki N, Bae HJ, Toyoda K; CRCS-K Investigators and the SAMURAI Study Investigators. Tanaka K, et al. Among authors: park el. Stroke. 2020 Apr;51(4):1150-1157. doi: 10.1161/STROKEAHA.119.027275. Epub 2020 Feb 26. Stroke. 2020. PMID: 32098607 Free article.
Transesophageal Echocardiography in Ischemic Stroke With Atrial Fibrillation.
Tanaka K, Koga M, Lee KJ, Kim BJ, Mizoguchi T, Park EL, Lee J, Yoshimura S, Cha JK, Lee BC, Koge J, Bae HJ, Toyoda K; CRCS‐K Investigators, the SAMURAI Study Investigators. Tanaka K, et al. Among authors: park el. J Am Heart Assoc. 2021 Nov 16;10(22):e022242. doi: 10.1161/JAHA.121.022242. Epub 2021 Nov 6. J Am Heart Assoc. 2021. PMID: 34743551 Free PMC article.
Prediction of recurrent stroke among ischemic stroke patients with atrial fibrillation: Development and validation of a risk score model.
Kim BJ, Lee KJ, Park EL, Tanaka K, Koga M, Yoshimura S, Itabashi R, Cha JK, Lee BC, Akiyama H, Nagakane Y, Lee J, Toyoda K; SAMURAI Study Investigators; Bae HJ; CRCS-K Investigators. Kim BJ, et al. Among authors: park el. PLoS One. 2021 Oct 8;16(10):e0258377. doi: 10.1371/journal.pone.0258377. eCollection 2021. PLoS One. 2021. PMID: 34624070 Free PMC article.
Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.
Song KR, Chapagain RH, Tamrakar D, Shrestha R, Kanodia P, Chaudhary S, Wartel TA, Yang JS, Kim DR, Lee J, Park EL, Cho H, Lee J, Thaisrivichai P, Vemula S, Kim BM, Gupta B, Saluja T, Pansuriya RK, Ganapathy R, Baik YO, Lee YJ, Jeon S, Park Y, Her HL, Park Y, Lynch JA. Song KR, et al. Among authors: park el. Lancet Glob Health. 2024 May;12(5):e826-e837. doi: 10.1016/S2214-109X(24)00059-7. Lancet Glob Health. 2024. PMID: 38614631 Free PMC article. Clinical Trial.
Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening.
Joh HS, Yeats C, Shaw A, Poudyal N, Gallagher P, Kim JH, Shaikh A, Seo HJ, Chi KK, Prifti K, Cho A, Sujan MJ, Eraly E, Pham KD, Shrestha S, Aboushady AT, Pak G, Jang G, Park EL, Seo HW, Abudahab K, Taylor BEW, Clark A, Dolabella B, Yoon H, Han J, Kwon SY, Marks F, Stelling J, Aanensen DM, MacWright WR, Holm M. Joh HS, et al. Among authors: park el. Clin Infect Dis. 2023 Dec 20;77(Suppl 7):S507-S518. doi: 10.1093/cid/ciad634. Clin Infect Dis. 2023. PMID: 38118007 Free PMC article.
Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal.
Chapagain RH, Maharjan J, Adhikari S, Thapa P, Kunwar K, Giri BR, Shrestha NJ, Shrestha AK, Shrestha SK, Tamang SM, Cho H, Park EL, Lee J, Lee J, Kim DR, Yang JS, Saluja T, Wartel A, Lynch J, Song KR. Chapagain RH, et al. Among authors: park el. Hum Vaccin Immunother. 2023 Aug 1;19(2):2239680. doi: 10.1080/21645515.2023.2239680. Hum Vaccin Immunother. 2023. PMID: 37539816 Free PMC article. Review.
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose.
Capeding MR, Tadesse BT, Sil A, Alberto E, Kim DR, Park EL, Park JY, Yang JS, Eluru JR, Jo SK, Kim H, Yang SY, Ryu JH, Park H, Shin JH, Lee Y, Kim JH, Mojares ZR, Wartel TA, Sahastrabuddhe S. Capeding MR, et al. Among authors: park el. NPJ Vaccines. 2022 Jan 27;7(1):12. doi: 10.1038/s41541-022-00434-8. NPJ Vaccines. 2022. PMID: 35087084 Free PMC article.
16 results